The use of the tissue adhesive enbucrilate (histoacryl) in the treatment of symptomatic nephroptosis.
OBJECTIVE
To evaluate the use of the tissue adhesive enbucrilate in the treatment of symptomatic nephroptosis.


METHODS
We performed adhesive nephropexy in 9 patients who presented with well-documented symptomatic nephroptosis that was demonstrated with intravenous pyelography and/or radionuclide renogram studies. The ptotic kidney was fixed on the psoas muscle using 0.5 ml of enbucrilate (Histoacryl).


RESULTS
Adhesive nephropexy was successful in all 9 patients. Average operative time was 37 min. Postoperative opioid analgesia duration and hospital stay were limited (mean 2 and 4.4 days, respectively). Most patients returned to normal activity within 2 weeks (mean 14.2 days). Mean follow-up was 25 months and showed postoperatively a good anatomical result in radiographic studies as well as significant pain alleviation (mean 1 vs. 7 preoperatively, on a 10-point scale, p < 0.005 Wilcoxon rank test).


CONCLUSIONS
The tissue adhesive enbucrilate seems to be a safe, efficient agent to obtain good results in a simple, quick approach in the surgical treatment of symptomatic nephroptosis.
Gyftopoulos
Kostis I
KI
Department of Urology, Patras University Hospital, Rio, Patras, Greece. kgyftop@slot.gr
Fokaefs
Eleftherios
E
Barbalias
G A
GA
D000328:Adult; D004659:Enbucrilate; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007668:Kidney / Q000002:abnormalities* / Q000601:surgery*; D008297:Male; D014014:Tissue Adhesives
D014014:Tissue Adhesives; D004659:Enbucrilate